Stock that will see action today: 23 January 2025
Hindustan Unilever has acquired online premium skincare brand Minimalist for ₹2,955 crore, according to an exchange filing. The FMCG major has signed the agreement to acquire 90.5 per cent shareholding. This move from the FMCG giant will add Minimalist to the company’s Beauty & Wellbeing portfolio as it branches out to high-demand sectors.
Housing and Urban Development Corporation Ltd has signed a Memorandum of Understanding (MoU) with VPPL, a joint venture of JNPA (Government of India) and Maharashtra Maritime Board (MMB), an entity of the Government of Maharashtra. “Through this MoU, HUDCO shall explore and provide funds up to Rs 25,000 crore for development of new ports/PPP projects of VPPL,” the filing said.
Zydus Lifesciences on Wednesday said the US health regulator has granted Orphan Drug Designation to Usnoflast, a product under development for the treatment of amyotrophic lateral sclerosis. The US Food Drug Administration’s Office grants orphan status to support development of medicines for the treatment of rare diseases that affect fewer than two lakh people in the US.
Waaree Energies on Wednesday said it has started commercial production of solar modules at its manufacturing facility in the US. Homegrown Waaree Energies is the first Indian renewable energy company to establish a PV module manufacturing facility in Brookshire, Texas, United States.
Piramal Critical Care, division of Piramal Pharma, has announced the US launch of Chlorpromazine Hydrochloride for Injection, USP. With this launch, PCC continues to expand its generic injectables portfolio.
Paras Defence and Space Technologies has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra, India, for the proposed Optics Park Project in Navi Mumbai, Maharashtra. This Optics Park Project is set to commence in 2028. Upon allocation of land and requisite subsidies by the Government of Maharashtra, the Company proposes to invest approximately ₹12,000 crore in the Optics Park over a period of 10 years.
Moody’s Ratings has changed Bharti Airtel’s outlook to positive and affirmed Baa3 ratings.
Laurus Labs informed the exchanges that the US drug regulator USFDA has issued Form 483 with one observations for the company’s arm in New Jersey, USA. Inspection was conducted for four days between January 13, 2025 to January 21, 2025.
Sammaan Capital said that its board has approved the opening of a Qualified Institutions Placement (QIP) offering at a floor price of f₹151.09 per share. The company had earlier received shareholders nod to raise funds through the issuance of equity shares.
– Shiva Cement Ltd, a subsidiary of JSW Cement Ltd, announced a ₹380-crore agreement with Bhushan Power and Steel Ltd (BPSL) for the development of a 1MTPA cement grinding unit.
Effwa Infra & Research, NSE-Emerge listed company, has received an export order worth $4.29 million from Afcons Infrastructure. The order involves the supply, installation, testing, and commissioning of EMI components for a 16.5 MLD WTP to upgrade the drinking water supply system in southern Abidjan, Gueyo, and its surrounding areas in Ivory Coast. It has to b executed within 9 months.
Results calendar: UltraTech Cement, Dr Reddy’s Laboratories, Hindustan Petroleum Corporation, Indus Towers, United Spirits, Adani Energy Solutions, Adani Green Energy, Amber Enterprises India, Capri Global Capital, Cyient, Dai-ichi Karkaria, Greaves Cotton, Indian Energy Exchange, KFin Technologies, Mankind Pharma, Mphasis, Nippon Life India Asset Management, Senores Pharmaceuticals, Sona BLW Precision Forgings, Spandana Sphoorty Financial, Suryoday Small Finance Bank, Syngene International, Tata Teleservices, Tejas Networks, Thyrocare Technologies, Ujjivan Small Finance Bank, V2 Retail, and Zee Entertainment Enterprises
